Viewing Study NCT03933956


Ignite Creation Date: 2025-12-24 @ 11:21 PM
Ignite Modification Date: 2025-12-29 @ 12:07 AM
Study NCT ID: NCT03933956
Status: TERMINATED
Last Update Posted: 2020-12-17
First Post: 2019-04-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Metabolic Effects of the SGLT-2 Inhibitor Empagliflozin in Patients With Diabetic Nephropathy (MEDiaN)
Sponsor: Singapore General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module